Head-to-head · free

Revvity, Inc. vs SOPHiA GENETICS S.A.

RVTY vs SOPH — return on capital, cash generation, margins and balance sheet side by side.

RVTY

2 / 4

measures where RVTY leads

SOPH

2 / 4

measures where SOPH leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureRVTY · FY2025SOPH
Revenue$2.9B—
Net income$241.2M—
Revenue growth (yearly, multi-year)-6.8%—
Free cash flow$509.4M—
Free cash flow margin17.8%—
Net cash / (debt)——
ROIC2.9%—
Return on equity3.2%-110.0%
Gross margin54.8%67.4%
Operating margin12.5%-91.8%
Net debt / EBITDA3.02x0.37x

Figures are as reported by each company; latest fiscal year shown.

Where Revvity, Inc.'s cash went (FY2025)

Capital spending
$73.5M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full RVTY profile →

Where SOPHiA GENETICS S.A.'s cash went

Not reported yet.

Full SOPH profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons